EPISODE · Apr 11, 2019 · 10 MIN
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - April '19 update
from Stock Day Media · host Stock Day Media
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to talk in detail about multiple wholly owned divisions, including Skyline Medical, Tumor Genesis, and Helomics. automated # breast cancer # Cytopatch # D-chip # FDA cleared # Lung cancer # medical devices # Ovvarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis # Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to talk in detail about multiple wholly owned divisions, including Skyline Medical, Tumor Genesis, and Helomics. automated # breast cancer # Cytopatch # D-chip # FDA cleared # Lung cancer # medical devices # Ovvarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis # Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - April '19 update
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m